Short-Term Outcomes of E-TZF with Synthetic Bone Graft Usage
Patients who underwent dental implant surgery with simultaneous application of E-TZF and synthetic bone grafts in the maxilla between 2018 and 2019 were retrospectively evaluated. The findings showed that the augmented buccal bone width reduction and marginal bone loss occurred at a low rate, while the implant survival rate was 98.64%.
📄 Please review the PDF for all study data and statistical analyses.